Mesenchymal stem cells modified with angiotensin-converting enzyme 2 are superior for amelioration of glomerular fibrosis in diabetic nephropathy
Qingzhen Liu, Shasha Lv, Jiaxi Liu, Shanshan Liu, Yinghui Wang, Gang Liu
Topics & Concepts
Mesenchymal stem cellDiabetic nephropathyMedicineFibrosisGlomerulosclerosisAngiotensin IITransplantationNephropathyRenin–angiotensin systemKidneyIn vivoAngiotensin-converting enzyme 2Cancer researchDiabetes mellitusEndocrinologyInternal medicineBiologyPathologyProteinuriaReceptorInfectious disease (medical specialty)DiseaseCoronavirus disease 2019 (COVID-19)Blood pressureBiotechnologyChronic Kidney Disease and DiabetesTissue Engineering and Regenerative MedicineMesenchymal stem cell research